Dr. Eva Feldman was given the award presented annually for an individual’s outstanding contributions to peripheral clinical neurophysiology research by the American Clinical Neurophysiology Society. The first woman to receive the honor in the award's 25-year history.
After finishing his 6-month sabbatical at the NeuroNetwork for Emerging Therapies, Dr. Charles shared about his experience of Ann Arbor, research in diabetic neuropathy and cognitive decline, and working at the University of Michigan.
The NeuroNetwork for Emerging Therapies welcomes five new collaborating faculty whose interests range from bioinformatics and stem cells to isolating cells for ALS research and growing mini-brains.
Drs. Brain Callaghan and Evan Reynolds publish insight into the cause of this costly problem.
Diabetes Care recently published a groundbreaking discovery by Michigan Medicine researchers, including six NeuroNetwork faculty, of a protein that is likely behind the higher risk of death and complications from COVID-19 for diabetes patients.
